Dose-escalation Study of Intravenous Liposomal Vinorelbine Tartrate Injection in Patients With Advanced Malignancy
Status:
Completed
Trial end date:
2020-10-06
Target enrollment:
Participant gender:
Summary
This is a phase I/IIa, Open label, Dose-escalation Study Investigating the Safety,
Tolerability, and Pharmacokinetics of Intravenous Liposomal Vinorelbine Tartrate Injection in
Patients with Advanced Malignancy.